Vai al contenuto

Interazioni tra farmaci

Ethinyl estradiol-drospirenone + Ombitasvir / paritaprevir / ritonavir

Gravità: Controindicata

Ethinyl estradiol-drospirenone and Ombitasvir / paritaprevir / ritonavir: contraindicated interaction.

Ultimo aggiornamento

Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.

Il contenuto clinico di questa pagina è disponibile solo in inglese.

Sintesi

Ethinyl estradiol-containing contraceptives given with this HCV regimen have been associated with significant ALT elevations. The regimen is labeled as contraindicated with ethinyl estradiol products. The interaction is hepatic rather than a CYP3A4 effect of drospirenone.

Cosa significa questa interazione in parole semplici

Ethinyl estradiol-drospirenone and Ombitasvir / paritaprevir / ritonavir are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Livello di evidenza: High

Perché avviene

Mechanism of ALT elevation is not fully established; it is a labeled hepatotoxicity signal with ethinyl estradiol and this regimen.

Cosa fare

Do not combine; switch to a progestin-only or non-hormonal contraceptive before starting the regimen. Ethinyl estradiol products may be resumed about 2 weeks after completing therapy.

Cosa chiedere al farmacista

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Per gli utenti Pro+

Sblocca la pagina completa

Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Ethinyl estradiol-drospirenone e Ombitasvir / paritaprevir / ritonavir, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.

Domande frequenti

Can I take Ethinyl estradiol-drospirenone with Ombitasvir / paritaprevir / ritonavir?

MediHelp rates the interaction as contraindicated. Ethinyl estradiol-drospirenone and Ombitasvir / paritaprevir / ritonavir are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Ethinyl estradiol-containing contraceptives given with this HCV regimen have been associated with significant ALT elevations. The regimen is labeled as contraindicated with ethinyl estradiol products. The interaction is hepatic rather than a CYP3A4 effect of drospirenone.

How serious is the interaction between Ethinyl estradiol-drospirenone and Ombitasvir / paritaprevir / ritonavir?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not combine; switch to a progestin-only or non-hormonal contraceptive before starting the regimen. Ethinyl estradiol products may be resumed about 2 weeks after completing therapy.

What other medicines interact with Ethinyl estradiol-drospirenone?

MediHelp also lists interactions of Ethinyl estradiol-drospirenone with, for example, Fezolinetant, Ombitasvir / paritaprevir / ritonavir and dasabuvir, Tranexamic acid. The full list is on the Ethinyl estradiol-drospirenone page.

Monografie complete, posologie e verifica delle interazioni nell'app MediHelp

Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.

Sfoglia dalla A alla Z · Interazioni tra farmaci

Scarica l'app Accedi